A 48-year-old male patient presented with a Pancoast tumor of the right lung and a serum alpha-fetoprotein (αFP) at 39,000 ng/ml. Alpha-fetoprotein is a tumor marker found elevated in patients with hepatocellular carcinoma (HCC), germ cell or stromal tumors of the ovary and nonseminomatous testicular cancer. Occasionally, this tumor marker may rise in non-neoplastic conditions such as cirrhosis and hepatitis and only exceptionally in rare cancers with hepatoid differentiation. We present our case report and review the English literature for αFP-producing lung carcinomas. To the best of our knowledge this is the first report in the literature of an αFP producing Pancoast tumor.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.lungcan.2012.05.102 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Interstitial High-Dose-Rate Brachytherapy Combined with External Beam Radiation Therapy for Dose Escalation in the Primary Treatment of Locally Advanced, Non-Resectable Superior Sulcus (Pancoast) Tumors: Results of a Monocentric Retrospective Study.
J Clin Med
December 2024
Department of Radiotherapy and Radiation Oncology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.
: To analyze the results of interstitial (IRT) high-dose-rate (HDR) brachytherapy (BT) in the primary treatment of patients with unresectable superior sulcus tumors (SST) combined with external beam radiotherapy (EBRT). : Between 2013 and 2023, seven patients with unresectable SST were treated with combined BT and EBRT with or without concomitant chemotherapy. The patients' median age was 64 years (range, 49-79 years) and median tumor volume was 146.
View Article and Find Full Text PDFContinuous epidural analgesia and interscalene brachial plexus block as postoperative analgesia for Pancoast tumor resection: a case report.
AME Case Rep
August 2024
Department of Anesthesiology and Pain Medicine, Juntendo University Hospital, Tokyo, Japan.
Article Synopsis
- Pancoast tumor resection surgery can lead to intense postoperative pain, particularly due to potential damage to the brachial plexus, causing shoulder and upper extremity pain.
- A continuous brachial plexus block and continuous epidural analgesia were used to manage this pain in a 58-year-old patient undergoing left upper lobectomy and chest wall resection.
- Post-surgery, the patient's pain was effectively controlled, maintaining low levels of pain (2-3 for shoulder and 0-1 for wound pain) using a combination of ropivacaine and fentanyl for the analgesia methods.
Multifocal Mycotic Aneurysms and Pseudoaneurysms.
JACC Case Rep
August 2024
Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston Texas, USA.
Article Synopsis
- Mycotic aneurysms and pseudoaneurysms are rare but pose significant challenges in diagnosis and treatment, especially in patients with a history of infections.
- A case study of a 74-year-old male with bladder cancer illustrates the complexity of diagnosing multifocal mycotic aneurysms and pseudoaneurysms, which were initially mistaken for a Pancoast tumor.
- The case emphasizes the need for healthcare providers to consider mycotic aneurysms in patients with infection histories and the crucial role of Computed Tomography Angiography for early identification.
Percutaneous cervical cordotomy for managing refractory pain in a patient with a Pancoast tumor: A case report.
World J Clin Cases
July 2024
Department of Anesthesiology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Background: According to the World Health Organization analgesic ladder, cancer-related pain generally begins with pharmacotherapy in a stepwise approach. Nevertheless, some patients continue to experience poorly controlled pain despite medications, particularly when considering adverse effects and self-care quality. Percutaneous cervical cordotomy is an alternative interventional procedure for unremitting unilateral intractable cancer-related pain.
View Article and Find Full Text PDFPET-driven SBRT plus pembrolizumab as first-line therapy against pleomorphic Pancoast cancer appears beneficial, probably due to high equivalent doses of SBRT on photopenic necrotic core and synergic immune system stimulation of immunoradiotherapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!